Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09
Finberg KE – Iron–refractory iron deficiency anemia (IRIDA) is an autosomal recessive disorder characterized by iron deficiency anemia unresponsive to oral iron treatment but partially responsive to parenteral iron therapy. A discussion of the clinical presentation of IRIDA, the molecular genetics of this disorder, and recent studies elucidating the underlying pathophysiology are presented.
Related Articles
Iron deficiency anemia in infancy and reach and grasp development
Infant Behavior and Development, 11/18/09
Relevance Score: 91%
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/14/09
Relevance Score: 91%
Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
Hemodialysis International, 11/05/09
Relevance Score: 90%
Trichuris dysentery syndrome: a common cause of chronic iron deficiency anemia in adults in an endemic area
Gastrointestinal Endoscopy, 11/03/09
Relevance Score: 90%
Prevalence and pathogenesis of anemia in Inflammatory Bowel disease. Influence of anti-tumor necrosis factor-alpha treatment
Haematologica, 10/12/09
Relevance Score: 90%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Arterio-Arterial Anastomoses do not Prevent the Development of Twin Anemia-Polycythemia Sequence
Placenta, 12/10/09
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy
Biology of Blood and Marrow Transplantation, 12/09/09
Molecular Analysis of gamma-Globin Promoters, HS-111 and 3'HS1, in beta-thalassemia Intermedia Patients Associated with High Levels of Hb F
Hemoglobin, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


